Abstract

Abstract
Disclosure of HIV serostatus by pregnant women to their sexual partners is critical for the successful prevention of mother to child transmission of HIV. This study examined the magnitude and factors associated with disclosure of HIV serostatus by pregnant women attending antenatal care services to their sexual partners in northwest Ethiopia.
Institutional-based cross-sectional study design was employed from June to September 2013. All HIV positive pregnant women attending antenatal care follow up at government health facilities of Gondar, Bahir Dar and Metema town during the data collection period were included in the study. Data were collected by using pretested and structured interview questionnaire. Data analyses were done using SPSS for windows version 17.0. Multivariable analyses were applied to identify the relative effect of explanatory variables on the dependent variable.
Out of the 263 HIV positive pregnant women participated in the study, 236 (89.7%) of them disclosed their HIV test result to their sexual partners. Knowing HIV serostatus of the sexual partner [AOR: 13.4, 95%CI: (2.6, 70.2)], knowing the importance of HIV serostatus disclosure [AOR: 10.3, 95%CI: (1.1, 98.7)] and being a rural resident [AOR: 0.2, 95%CI: (0.0, 1.0)] were the independent factors that determine HIV positive serostatus disclosure.
This study showed that the magnitude of HIV serostatus disclosure by HIV positive pregnant women attending antenatal care services to their sexual partners was high. However, this doesn’t mean that there will be no need for further intervention activities as significant proportions of the study population still demonstrates nondisclosure. So, it is crucially important for HIV prevention programs to focus on factors, such as residence, increasing people’s awareness about HIV and ensuring smooth communication between sexual partners concerning HIV serostatus to address to problem.
Keywords: Disclosure of HIV serostatus; HIV positive pregnant women; Sexual partner

Copyright conditions:
Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s).
Authors grant IJIC permission to publish the article and identify itself as the original publisher.
Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles.
In summary, anyone is free:
• to copy, distribute, and display the work;
• to make derivative works;
• to make commercial use of the work;
as long as:
• the original author must be given credit;
• for any reuse or distribution, it must be made clear to others what the license terms of this work are;
• any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above.
Authors' certification:
In submitting a manuscript to IJIC, authors are requested to certify that:
• They are authorized by their co-authors to enter into these arrangements.
• They warrant, on behalf of themselves and their co-authors, that:
o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission;
o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
o they have taken due care to ensure the integrity of the article.